# CT-Agent：融合大型语言模型推理能力的临床试验多智能体系统

发布时间：2024年04月23日

`Agent` `人工智能`

> CT-Agent: Clinical Trial Multi-Agent with Large Language Model-based Reasoning

# 摘要

> 大型语言模型（LLMs）和多智能体系统在处理自然语言任务上表现出色，但在临床试验应用方面却遭遇难题，这主要是因为它们难以获取外部知识。为了克服这一限制，我们提出了一个集成为临床试验工具的解决方案，这些工具能够整合并预测最新的医疗数据。我们设计了临床代理系统（CT-Agent），这是一个专门针对临床试验任务的多智能体系统，它结合了GPT-4、多智能体架构、LEAST-TO-MOST策略以及ReAct推理技术。这一整合显著提升了LLMs在临床领域的性能，并带来了创新功能。我们的系统能够独立管理整个临床试验流程，在计算基准测试和专家评审中均显示出了显著的效率提升。

> Large Language Models (LLMs) and multi-agent systems have shown impressive capabilities in natural language tasks but face challenges in clinical trial applications, primarily due to limited access to external knowledge. Recognizing the potential of advanced clinical trial tools that aggregate and predict based on the latest medical data, we propose an integrated solution to enhance their accessibility and utility. We introduce Clinical Agent System (CT-Agent), a Clinical multi-agent system designed for clinical trial tasks, leveraging GPT-4, multi-agent architectures, LEAST-TO-MOST, and ReAct reasoning technology. This integration not only boosts LLM performance in clinical contexts but also introduces novel functionalities. Our system autonomously manages the entire clinical trial process, demonstrating significant efficiency improvements in our evaluations, which include both computational benchmarks and expert feedback.

[Arxiv](https://arxiv.org/abs/2404.14777)